Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5-(1-hydroxy-2-((2-(2-methoxyphenoxy)ethyl)amino)ethyl)-2-methylbenzenesulfonamide
2. Amosulalol
3. Ym 09538
4. Ym-09538
1. Amosulalol Hcl
2. 93633-92-2
3. 70958-86-0
4. Amosulalol Monohydrochloride
5. Ym 09538
6. Ym-09538
7. 5-(1-hydroxy-2-((2-(2-methoxyphenoxy)ethyl)amino)ethyl)-2-methylbenzenesulfonamide Hydrochloride
8. Lowgan
9. Amosulalol Hydrochloride [jan]
10. Amosulalol (hydrochloride)
11. 4o4s698pee
12. 93633-92-2 ( Hcl)
13. 5-[1-hydroxy-2-[2-(2-methoxyphenoxy)ethylamino]ethyl]-2-methylbenzenesulfonamide;hydrochloride
14. Amosulalolhcl
15. Unii-4o4s698pee
16. Lowgan (tn)
17. Schembl50631
18. Amosulalol Hydrochloride (jp17)
19. Chebi:31208
20. Dtxsid00918277
21. (+-)-5-hydroxy-2-(2-(2-methoxyphenoxy)ethylamino)ethyl)-2-methylbenzolsulfonamid Hydrochlorid
22. Amosulalol Hydrochloride [mart.]
23. Amosulalol Hydrochloride [who-dd]
24. Amosulalol Monohydrochloride [mi]
25. Benzenesulfonamide, 5-(1-hydroxy-2-((2-(2-methoxyphenoxy)ethyl)amino)ethyl)-2-methyl-, Hydrochloride, (+-)-
26. Benzenesulfonamide, 5-(1-hydroxy-2-((2-(2-methoxyphenoxy)ethyl)amino)ethyl)-2-methyl-, Monohydrochloride
27. D01469
28. Q27260271
29. 5-(1-hydroxy-2-{[2-(2-methoxyphenoxy)ethyl]amino}ethyl)-2-methylbenzene-1-sulfonamide--hydrogen Chloride (1/1)
30. Benzenesulfonamide, 5-(1-hydroxy-2-((2-(2-methoxyphenoxy)ethyl)amino)ethyl)-2-methyl-, Hydrochloride (1:1)
31. Benzenesulfonamide, 5-(1-hydroxy-2-((2-(2-methoxyphenoxy)ethyl)amino)ethyl)-2-methyl-, Hydrochloride, (+/-)-
Molecular Weight | 416.9 g/mol |
---|---|
Molecular Formula | C18H25ClN2O5S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 9 |
Exact Mass | 416.1172708 g/mol |
Monoisotopic Mass | 416.1172708 g/mol |
Topological Polar Surface Area | 119 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 510 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Adrenergic beta-Antagonists
Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Adrenergic alpha-Antagonists
Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)
ABOUT THIS PAGE
17
PharmaCompass offers a list of Amosulalol Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Amosulalol Hydrochloride manufacturer or Amosulalol Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amosulalol Hydrochloride manufacturer or Amosulalol Hydrochloride supplier.
PharmaCompass also assists you with knowing the Amosulalol Hydrochloride API Price utilized in the formulation of products. Amosulalol Hydrochloride API Price is not always fixed or binding as the Amosulalol Hydrochloride Price is obtained through a variety of data sources. The Amosulalol Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Amosulalol Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Amosulalol Hydrochloride, including repackagers and relabelers. The FDA regulates Amosulalol Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Amosulalol Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Amosulalol Hydrochloride supplier is an individual or a company that provides Amosulalol Hydrochloride active pharmaceutical ingredient (API) or Amosulalol Hydrochloride finished formulations upon request. The Amosulalol Hydrochloride suppliers may include Amosulalol Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Amosulalol Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Amosulalol Hydrochloride Drug Master File in Japan (Amosulalol Hydrochloride JDMF) empowers Amosulalol Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Amosulalol Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Amosulalol Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Amosulalol Hydrochloride suppliers with JDMF on PharmaCompass.
Amosulalol Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Amosulalol Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Amosulalol Hydrochloride GMP manufacturer or Amosulalol Hydrochloride GMP API supplier for your needs.
A Amosulalol Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Amosulalol Hydrochloride's compliance with Amosulalol Hydrochloride specifications and serves as a tool for batch-level quality control.
Amosulalol Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Amosulalol Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Amosulalol Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Amosulalol Hydrochloride EP), Amosulalol Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Amosulalol Hydrochloride USP).